__NUXT_JSONP__("/drugs/Niraparib_Tosylate_Monohydrate", (function(a,b,c,d){return {data:[{drug:{slug:a,emaEpar:[],fdaDrugLabel:[],id:a,nciThesaurus:{casRegistry:"1613220-15-7",chebiId:b,chemicalFormula:b,definition:"An orally bioavailable, hydrated, tosylate salt form of niraparib, an inhibitor of poly (ADP-ribose) polymerase (PARP) types 1 and 2 (PARP-1 and -2), with antineoplastic activity. Upon administration, niraparib binds to and inhibits the activity of PARP-1 and -2, thereby inhibiting PARP-1 and -2-mediated DNA repair, enhancing the accumulation of DNA strand breaks, promoting genomic instability and resulting in apoptosis. The PARP family of proteins catalyzes post-translational ADP-ribosylation of nuclear proteins and is activated by single-strand DNA (ssDNA) breaks.",fdaUniiCode:"195Q483UZD",identifier:"C133238",preferredName:c,semanticType:"Pharmacologic Substance",subclassOf:["C62554"],synonyms:["2H-Indazole-7-carboxamide, 2-(4-(3S)-3-piperidinylphenyl)-, 4-Methylbenzenesulfonate, Hydrate (1:1:1)","NIRAPARIB TOSYLATE MONOHYDRATE",c,"Zejula"]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FNiraparib_Tosylate_Monohydrate",extension:".json",createdAt:d,updatedAt:d}}],fetch:{},mutations:void 0}}("Niraparib_Tosylate_Monohydrate","","Niraparib Tosylate Monohydrate","2021-10-30T13:31:43.043Z")));